VIVA BIOTECH

1873
1.2153.57% ( -0.045 )
Delay Closed: Nov 16, 16:08:11

Overview

VIVA BIOTECH (1873)

Viva Biotech Holdings, an investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical cu...

Open
1.260
High
1.265
Low
1.200
Prev. Close
1.260
Volume
3.37M
Turnover
4.09M
Avg Price
1.212
Bid/Ask Ratio
-17.65%
Amplitude
5.16%
52wk High
2.860
Volume Ratio
0.84
Turnover Ratio
0.16%
52wk Low
1.040
HK Mkt Cap
2.54B
Market CapHKD
2.54B
P/ETTM
12.41
P/EDynamic
13.79
P/EStatic
--
EPSTTM
0.0979
EPSDynamic
0.0881
EPSStatic
--
BVPS
2.18
P/B
0.56
HK Shares
2.09B
Dividend YieldTTM
--
DividendTTM
--
Shares
2.09B
Min lot size
500
Currency
HKD

VIVA BIOTECH Analyst Rating

View more

Forecast & Rating

Apr 2, 2026
Price forecast
HK$2.81131.02%
Forecast & RatingStrong buy
1analysts
  • Strong buy100.00%
  • Buy0.00%
  • Hold0.00%
  • Sell0.00%
  • Strong sell0.00%

Daily Events

  1. Jul, 3

    Viva Biotech opened low at HK$1.210 in the morning session, quickly surged to an intraday high of HK$1.270, then fluctuated narrowly around HK$1.250 in the afternoon, closing up 5.93% at HK$1.250, ending a recent losing streak. The company's ongoing share repurchases for cancellation (e.g., at HK$1.12 per share), coupled with a 31.4% YoY jump in full-year 2025 net profit to RMB 220 million, offset a 6.63% revenue decline, while the net profit margin held steady at 10.91%, boosting sentiment. The stock remains 61.77% below its 52-week high of HK$3.27 and down 28.98% YTD, but has reclaimed its 20-day moving average of HK$1.157, though still below the 60-day MA of HK$1.464, indicating repaired short-term momentum but lingering medium-term headwinds. However, after-hours disclosure of 6.22 million RSUs granted to CDMO staff at HK$1.08 each could pose near-term dilution.

News

Bullish vs. Bearish — Last 3 Months

1.1k followers · 0 opinions
▲Bullish50%
50%Bearish▼